Cart
sales@molnova.com
NSC19005
CAS No. 5452-87-9
NSC19005( NSC19005 | NSC-19005 | NSC 19005 )
Catalog No. M17535 CAS No. 5452-87-9
NSC19005 is structurally related to Betahistine. NSC19005 is a dimer of Betahistine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 5MG | 36 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSC19005
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC19005 is structurally related to Betahistine. NSC19005 is a dimer of Betahistine.
-
DescriptionNSC19005 is structurally related to Betahistine. NSC19005 is a dimer of Betahistine.
-
In VitroBetahistine (0-10 μM) inhibits [125I]iodoproxyfan binding to membranes of CHO (rH3(445)R) and CHO (hH3(445)R) cells with IC50 values of 1.9 μM and 3.3 μM, respectively. Lead to Ki values of 1.4 μM and 2.5 μM, respectively.
-
In Vivo——
-
SynonymsNSC19005 | NSC-19005 | NSC 19005
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5452-87-9
-
Formula Weight241.34
-
Molecular FormulaC15H19N3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(CCc1ncccc1)CCc1ncccc1
-
Chemical NameN-methyl-2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)ethan-1-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lewin JL,et al.Validation of density functional modeling protocols on experimental bis(mu-oxo)/mu-eta2:eta2-peroxo dicopper equilibria. J Biol Inorg Chem. 2007 Nov;12(8):1221-34.
molnova catalog
related products
-
Thalidomide-5-methyl
Thalidomide-5-methyl is the Thalidomide-based cereblon (CRBN) ligand used in the recruitment of CRBN protein.
-
6-Methoxyfraxinellon...
6-Methoxyfraxinellone
-
Bendazac L-lysine
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
